1 / 44

Pneumonia

Pneumonia. Pneumonia. Acute inflammation of lung caused by microorganism Leading cause of death until 1936 Discovery of sulfa drugs and penicillin. Pneumonia. Still leading cause of death from infectious disease. Predisposing Factors. Defense mechanisms are incompetent or overwhelmed

starlar
Download Presentation

Pneumonia

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Pneumonia

  2. Pneumonia • Acute inflammation of lung caused by microorganism • Leading cause of death until 1936 • Discovery of sulfa drugs and penicillin

  3. Pneumonia • Still leading cause of death from infectious disease

  4. Predisposing Factors • Defense mechanisms are incompetent or overwhelmed • Decreased cough and epiglottal reflexes (may allow aspiration)

  5. Predisposing Factors • Mucociliary mechanism impaired • Pollution • Cigarette smoking • Upper respiratory infections • Tracheal intubation • Aging

  6. Predisposing Factors • Alteration of leukocytes from malnutrition • Increased frequency of gram- negative bacilli (leukemia, diabetes, alcoholism)

  7. Acquisition of Organisms • Aspiration from nasopharynx, oropharynx • Inhalation of microbes • Hematogenous spread from primary infection elsewhere

  8. Types of Pneumonia • Organisms implicated • S. pneumoniae • Legionella • Mycoplasma • Chlamydia • S. aureus • Respiratory viruses

  9. Types of Pneumonia • Community-acquired pneumonia (CAP) • Onset in community or during first 2 days of hospitalization • Highest incidence in winter • Smoking important risk factor

  10. Types of Pneumonia • Hospital-acquired pneumonia (HAP) • Occurs > 48 hours after admission; not incubating at time of hospitalization • Highest mortality rate of nosocomial infections

  11. Types of Pneumonia • Causes of HAP • Pseudomonas • Enterobacter • S. aureus • S. pneumoniae • Immunosuppressive therapy • General debility • Endotracheal intubation

  12. Types of Pneumonia • Classification of Patients with HAP • Severity of illness • Specific host or therapeutic factors predisposing to pathogens present • Early (5 days post admission) or late (more than 5 days post admission) onset

  13. Types of Pneumonia • Fungal pneumonia • Aspiration pneumonia • Sequelae occurring from abnormal entry of secretions into lower airway • Usually history of loss of consciousness • Gag and cough reflexes suppressed • Tube feedings risk factor

  14. Types of Pneumonia • Forms of aspiration pneumonia • Mechanical obstruction • Chemical injury • Bacterial infection

  15. Types of Pneumonia • Opportunistic pneumonia • Pneumocytis carnii • CMV • Fungi • Patients with severe protein-calorie malnutrition, immune deficiencies, chemotherapy/radiation recipients, and transplant recipients are at risk

  16. Types of Pneumonia • Opportunistic pneumonia • Clinical manifestations • Fever • Tachypnea • Tachycardia • Dyspnea • Nonproductive cough • Hypoxemia

  17. Pathophysiology: Pneumococcal Pneumonia • Congestion from outpouring of fluid into alveoli • Microorganisms multiply and spread infection, interfering with lung function

  18. Pathophysiology: Pneumococcal Pneumonia • Red hepatization • Massive dilation of capillaries • Alveoli fill with organisms, neutrophils, RBCs, and fibrin • Causes lungs to appear red and granular, similar to liver

  19. Pathophysiologic course of pneumococcal pneumonia Fig. 27-1

  20. Pathophysiology: Pneumococcal Pneumonia • Gray hepatization • Blood flow decreases • Leukocyte and fibrin consolidate in affected part of lung

  21. Pathophysiology: Pneumococcal Pneumonia • Resolution • Resolution and healing if no complications • Exudate lysed and processed by macrophages • Tissue restored

  22. Clinical Manifestations • CAP symptoms • Sudden onset of fever • Chills • Cough productive of purulent sputum • Pleuritic chest pain

  23. Clinical Manifestations • Confusion or stupor may manifest in older or debilitated patient • Physical exam findings • Dullness on percussion • Increased fremitus • Bronchial breath sounds • Crackles

  24. Clinical Manifestations • CAP (alternative manifestations) • Gradual onset • Dry cough • Headache • Myalgias • Fatigue • Sore throat • N/V/D

  25. Clinical Manifestations • Manifestations of viral pneumonia are variable • Chills • Fever • Dry and non-productive cough • Extrapulmonary symptoms

  26. Complications • Pleurisy • Pleural effusion • Usually is sterile and reabsorbed in 1-2 weeks or requires thoracentesis • Atelectasis • Usually clears with cough and deep breathing

  27. Complications • Delayed resolution • Persistent infection seen on x-ray as residual consolidation • Lung abscess (pus-containing lesions) • Empyema (purulent exudate in pleural cavity) • Requires antibiotics and drainage of exudate

  28. Complications • Pericarditis • From spread of microorganism • Arthritis • Systemic spread of organism • Exudate can be aspirated • Meningitis • Patient who is disoriented, confused, or somnolent should have lumbar puncture to evaluate meningitis

  29. Complications • Endocarditis • Microorganisms attack endocardium and heart valves • Manifestations similar to bacterial endocarditis

  30. Diagnostic Tests • History • Physical exam • Chest x-ray • Gram stain of sputum • Sputum culture and sensitivity • Pulse oximetry or ABGs • CBC, differential, chems • Blood cultures

  31. Collaborative Care • Antibiotic therapy • Oxygen for hypoxemia • Analgesics for chest pain • Antipyretics • Influenza drugs • Influenza vaccine • Fluid intake at least 3 L per day • Caloric intake at least 1500 per day

  32. Collaborative Care • Pneumococcal vaccine • Indicated for those at risk • Chronic illness such as heart and lung disease, diabetes mellitus • Recovering from severe illness • 65 or older • In long-term care facility

  33. Nursing Assessment • History of Predisposing/Risk Factors • Lung cancer • COPD • Diabetes mellitus • Debilitating disease • Malnutrition

  34. Nursing Assessment History of Predisposing/Risk Factors • AIDS • Use of antibiotics, corticosteroids, chemotherapy, immunosuppressants • Recent abdominal or thoracic surgery • Smoking, alcoholism, respiratory infections • Prolonged bed rest

  35. Nursing Assessment • Clinical Manifestations • Dyspnea • Nasal congestion • Pain with breathing • Sore throat • Muscle aches • Fever

  36. Nursing Assessment • Clinical Manifestations • Restlessness or lethargy • Splinting affected area • Tachypnea • Asymmetric chest movements • Use of accessory muscles • Crackles • Green or yellow sputum

  37. Nursing Assessment • Clinical Manifestations • Tachycardia • Changes in mental status • Leukocytosis • Abnormal ABGs • Pleural effusion • Pneumothorax on CXR

  38. Nursing Diagnoses • Ineffective breathing pattern • Ineffective airway clearance • Acute pain • Imbalanced nutrition: less than body requirements • Activity intolerance

  39. Planning • Goals: Patient will have • Clear breath sounds • Normal breathing patterns • No signs of hypoxia • Normal chest x-ray • No complications related to pneumonia

  40. Nursing Implementation • Teach nutrition, hygiene, rest, regular exercise to maintain natural resistance • Prompt treatment of URIs

  41. Nursing Implementation • Encourage those at risk to obtain influenza and pneumococcal vaccinations • Reposition patient q2h • Assist patients at risk for aspiration with eating, drinking, and taking meds

  42. Nursing Implementation • Assist immobile patients with turning and deep breathing • Strict asepsis • Emphasize need to take course of medication(s) • Teach drug-drug interactions

  43. Evaluation • Dyspnea not present • SpO2> 95 • Free of adventitious breath sounds • Clears sputum from airway

  44. Evaluation • Reports pain controlled • Verbalizes causal factors • Adequate fluid and caloric intake • Performs ADLs

More Related